Pfizer company headlines, earnings, strategy, leadership, and market-moving business updates.
Market data may be delayed. For informational purposes only. Not investment advice.
Ahead of Pfizer’s third-quarter 2026 results, market watchers are preparing for a double-digit dip in profit, underscoring how sensitive the company’s earnings outlook remains to new-product growth and shifting demand.
THE APEX TIMES
THE APEX TIMES
A healthcare-led rebound lifted Moderna sharply, while BioNTech and Pfizer followed. The move underscores how quickly market flows can shift across sectors, even among companies tied to the same underlying biotechnology platform.
THE APEX TIMES
A fresh comparison of two major U.S. pharma names frames AbbVie’s near-term outlook as increasingly tied to its immunology and inflammation franchise, and Pfizer’s fortunes as dependent on how quickly its next pipeline inflects, particularly in obesity drugs.
THE APEX TIMES
Pfizer’s stock climbed 2.96% on the latest trading day, ending at $29.21, even as the market pulled back.
THE APEX TIMES
A recent market comparison highlights Pfizer’s dividend yield near 6% versus General Mills around 7%, underscoring how investors screen different sectors for cash return.
THE APEX TIMES
A market-focused comparison highlighted Pfizer’s payout yield near 6.3% versus British American Tobacco’s around 6.0%, underscoring how investors weigh current income against business and balance-sheet risks.
THE APEX TIMES
A market write-up highlighted Pfizer’s dividend yield near 6.3% and set it against Healthpeak Properties’ roughly 6% yield as investors weigh income-focused positioning across different health-care-linked sectors.
THE APEX TIMES
A new market roundup comparing high-yield names put Pfizer’s indicated dividend yield at 6.3% versus Edison International’s 6.0%, underscoring how investors are weighing income against company-specific risk profiles.
THE APEX TIMES
A market-focused comparison highlights Pfizer’s dividend yield near 6% alongside Clorox, underscoring how investors are screening for income while weighing sustainability.
